Global Biochips Market Size study, by Type (DNA Chips, Lab-On-A-Chip, Protein Chips, Other Arrays) By Fabrication Technology (Microarrays, Microfluidics) By End User( Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Others) and Regional Forecasts 2019-2026

  • Report Id: BIZ 3105
  • Published Date: February, 2020
  • No of Pages: 200
  • Format: Electronic (PDF)
  • Publisher: Bizwit Research & Consulting LLP
  • Category:

Global Biochips Market is valued approximately USD 12.7 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 18.4% over the forecast period 2019-2026.
Biochips are miniaturized therapeutic devices utilized within molecular research laboratory to perform real-time biological reactions. Biochips are used for the screening of new drugs which could offer various benefits and evaluate the benefits and risk of pharmaceuticals compounds. biochip have its wide application in DNA applications such as gene expression, SNP (Single nucleotide polymorphisms) genotyping, cancer diagnosis & treatment, genomics and other. Biochips empower enormously parallel sub-atomic investigations to be done in a scaled down configuration with a high throughput. Rising incidences & treatment of cancer is the key driver for the growth of global biochip market. As rising incidences of cancer is anticipated to the rise in the demand of detection techniques. According to the World Health Organizations cancer is among the leading cause of mortality and morbidity globally that accounts for 8.8 million deaths globally in 2015, which is around one third of the total number of deaths. According to the American cancer Society by 2030, the global burden is anticipated to grow by 21.7 million new cancer cases and 13 million cancer deaths. Apart from this, increasing government funding, growth in personalized medicines and technical advances are further contributing towards market growth. However, knowledge constraint with respect to technical know-how impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Biochips market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to high research & development investment in the pharmaceutical & biotechnology sector, coupled with the rising market demand for precision medicine. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as owing to presence of large population base, increase in disposable income, and improvement in patient awareness about biochips would create lucrative growth prospects for the Biochips market across Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Agilent Technologies, Inc.
Perkinelmer, Inc.
Fluidigm Corporation
Illumina, Inc.
GE Healthcare
Bio-Rad Laboratories Inc.
Cepheid Inc.
Thermo Fisher Scientific, Inc.
Roche Diagnostics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
DNA Chips
Lab-On-A-Chip
Protein Chips
Other Arrays
By Fabrication Technology:
Microarrays
Microfluidics
By End User
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Biochips Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies:

Abbott Laboratories
Agilent Technologies, Inc.
Perkinelmer, Inc.
Fluidigm Corporation
Illumina, Inc.
GE Healthcare
Bio-Rad Laboratories Inc.
Cepheid Inc.
Thermo Fisher Scientific, Inc.
Roche Diagnostics

Countries:

U.S.
Canada
UK
Germany
France
China
India
Japan
Brazil
Mexico

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Biochips Market, by Region, 2017-2026 (USD Billion)
1.2.2. Biochips Market, by Type, 2017-2026 (USD Billion)
1.2.3. Biochips Market, by Fabrication Technology, 2017-2026 (USD Billion)
1.2.4. Biochips Market, by End User, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biochips Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biochips Market Dynamics
3.1. Biochips Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Biochips Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Biochips Market, by Type
5.1. Market Snapshot
5.2. Global Biochips Market by Type, Performance – Potential Analysis
5.3. Global Biochips Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Biochips Market, Sub Segment Analysis
5.4.1. DNA Chips
5.4.2. Lab-On-A-Chip
5.4.3. Protein Chips
5.4.4. Other Arrays
Chapter 6. Global Biochips Market, by Fabrication Technology
6.1. Market Snapshot
6.2. Global Biochips Market by Fabrication Technology, Performance – Potential Analysis
6.3. Global Biochips Market Estimates & Forecasts by Fabrication Technology 2016-2026 (USD Billion)
6.4. Biochips Market, Sub Segment Analysis
6.4.1. Microarrays
6.4.2. Microfluidics
Chapter 7. Global Biochips Market, by End User
7.1. Market Snapshot
7.2. Global Biochips Market by End User, Performance – Potential Analysis
7.3. Global Biochips Market Estimates & Forecasts by End User 2016-2026 (USD Billion)
7.4. Biochips Market, Sub Segment Analysis
7.4.1. Biotechnology and Pharmaceutical Companies
7.4.2. Hospitals and Diagnostics Centers
7.4.3. Academic & Research Institutes
7.4.4. Other End Users

Chapter 8. Global Biochips Market, Regional Analysis
8.1. Biochips Market, Regional Market Snapshot
8.2. North America Biochips Market
8.2.1. U.S. Biochips Market
8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Fabrication Technology breakdown estimates & forecasts, 2016-2026
8.2.1.3. End user breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Biochips Market
8.3. Europe Biochips Market Snapshot
8.3.1. U.K. Biochips Market
8.3.2. Germany Biochips Market
8.3.3. Rest of Europe Biochips Market
8.4. Asia-Pacific Biochips Market Snapshot
8.4.1. China Biochips Market
8.4.2. India Biochips Market
8.4.3. Japan Biochips Market
8.4.4. Rest of Asia Pacific Biochips Market
8.5. Latin America Biochips Market Snapshot
8.5.1. Brazil Biochips Market
8.5.2. Mexico Biochips Market
8.6. Rest of The World Biochips Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Agilent Technologies, Inc.
9.2.3. Perkinelmer, Inc.
9.2.4. Fluidigm Corporation
9.2.5. Illumina, Inc.
9.2.6. GE Healthcare
9.2.7. Bio-Rad Laboratories Inc.
9.2.8. Cepheid Inc.
9.2.9. Thermo Fisher Scientific, Inc.
9.2.10. Roche Diagnostics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOCHIPS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOCHIPS MARKET
TABLE 3. GLOBAL BIOCHIPS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY FABRICATION TECHNOLOGY 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY END USER 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. UK BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 62. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 66. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 67. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 68. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 69. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 70. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 71. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 72. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 73. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 74. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 75. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 76. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 77. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 78. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 79. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 80. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
FIG 1. GLOBAL BIOCHIPS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL BIOCHIPS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL BIOCHIPS MARKET, KEY TRENDS 2018
FIG 5. GLOBAL BIOCHIPS MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL BIOCHIPS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL BIOCHIPS MARKET, PEST ANALYSIS
FIG 8. GLOBAL BIOCHIPS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18. GLOBAL BIOCHIPS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL BIOCHIPS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 20. NORTH AMERICA BIOCHIPS MARKET 2016 & 2026 (USD BILLION)
FIG 21. EUROPE BIOCHIPS MARKET 2016 & 2026 (USD BILLION)
FIG 22. ASIA PACIFIC BIOCHIPS MARKET 2016 & 2026 (USD BILLION)
FIG 23. LATIN AMERICA BIOCHIPS MARKET 2016 & 2026 (USD BILLION)
FIG 24. GLOBAL BIOCHIPS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)

Choose License Type

Single user
$4,950
Enterprise User
$6,250
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.